Claudin-3 in Prostate Cancer
Author Information
Author(s): Bartholow Tanner L, Chandran Uma R, Becich Michael J, Parwani Anil V
Primary Institution: University of Pittsburgh School of Medicine
Hypothesis
Can claudin-3 serve as a biomarker for prostate cancer and its metastasis?
Conclusion
Claudin-3 is often overexpressed in prostate cancer, but it does not reliably predict the risk of metastasis.
Supporting Evidence
- PCa and Mets had the highest absolute staining for claudin-3.
- Both PCa and Mets had significantly higher staining than BPH and NAC.
- PIN had a lower, but non-significant, staining score than PCa and Mets.
Takeaway
This study looked at a protein called claudin-3 in prostate cancer samples to see if it could help doctors tell how serious the cancer is. They found that while claudin-3 is usually higher in cancer, it doesn't help predict if the cancer will spread.
Methodology
Immunohistochemistry was used to evaluate claudin-3 expression in tissue microarrays from various prostate tissue types.
Limitations
The study does not provide enough evidence to use claudin-3 as a marker for predicting metastasis risk.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website